Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40D1N | ISIN: US18978H3003 | Ticker-Symbol:
NASDAQ
12.11.24
21:57 Uhr
0,127 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CNS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
CNS PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur CNS PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.11.CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment228Segment featuring leading Neuro-Oncologist and Glioblastoma Key Opinion Leader, Professor Michael WellerAccess the segment here HOUSTON, TX / ACCESSWIRE / November 4, 2024 / CNS Pharmaceuticals, Inc....
► Artikel lesen
01.11.CNS Pharmaceuticals erhält Fristverlängerung für Nasdaq-Compliance1
01.11.CNS Pharmaceuticals granted Nasdaq compliance extension1
01.11.CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement166HOUSTON, TX / ACCESSWIRE / November 1, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary...
► Artikel lesen
01.11.CNS Pharmaceuticals, Inc. - 8-K, Current Report1
23.10.CNS Pharmaceuticals secures $3 million in registered direct offering8
23.10.CNS Pharmaceuticals sichert sich 3 Millionen US-Dollar durch registrierte Direktplatzierung2
CNS PHARMACEUTICALS Aktie jetzt für 0€ handeln
23.10.CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules284HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary...
► Artikel lesen
23.10.CNS Pharmaceuticals droht Delisting von der NASDAQ aufgrund von Preisregel5
23.10.Why CNS Pharmaceuticals (CNSP) Stock Is Up 86%4
23.10.CNS Pharmaceuticals faces NASDAQ delisting over price rule3
23.10.Pre-market Movers: CNS Pharmaceuticals, Zapata Computing, Farmmi, Mustang Bio, Spirit Airlines316BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.35 A.M. ET).In the Green CNS Pharmaceuticals, Inc. (CNSP) is up over 143%...
► Artikel lesen
23.10.CNS Pharmaceuticals, Inc. - 8-K, Current Report15
10.10.CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment185Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel GoldlustAccess the segment here HOUSTON, TX / ACCESSWIRE / October 10, 2024 / CNS...
► Artikel lesen
08.10.CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC234Live webcast fireside chat on Wednesday, October 16th at 4:00 PM ET HOUSTON, TX / ACCESSWIRE / October 8, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical...
► Artikel lesen
23.09.BioMedNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum4
23.09.CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum177Webcast presentation on Wednesday, September 25th at 1:55 PM CEST HOUSTON, TX / ACCESSWIRE / September 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical...
► Artikel lesen
12.09.CNS Pharmaceuticals erfüllt wieder NASDAQ-Anforderungen3
12.09.CNS Pharmaceuticals regains Nasdaq compliance3
12.09.CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement123HOUSTON, TX / ACCESSWIRE / September 12, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for...
► Artikel lesen
Seite:  Weiter >>
72 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
7,1,1